Medical Advertising Hall of Fame seeks nominations

Share this article:

The Medical Advertising Hall of Fame (MAHF) is seeking nominations for its 2008 class as it looks to a newer generation of industry contributors as potential honorees.

“The award is an enshrinement,” MAHF chairperson Scott Cotherman told MM&M, “It recognizes the life-long contributions of people who have made a significant impact on our industry in a variety of different areas, those who have also provided great service to the industry outside of their specific responsibilites.”

Cotherman, who is also CEO of Corbett Accel, said, “As you look at MAHF what you have very often is the most well-known, the names on the door, the best of the best. But that's not going to be the obvious group of people going forward with this new generation. It really gives us an opportunity to showcase people who have made great contributions, those who may not be the names on the door, if you will.” 

The deadline for MAHF nominations is Aug. 31.

MAHF seeks candidates based on two primary criteria:

• The candidate's achievement as evidenced by impact on brand and corporate success, leadership of his or her company, accomplishments in the creative, marketing/research or publishing disciplines and innovations in the advertisng process or structure.

• The contributions the candidate has made to enhance the reputation of the medical advertising industry through voluntary efforts outside his or her company. The nominee's record of advertising and service must have been accomplished in the advertising industry in the United States or with an American company abroad. The candidate must have completed his or her primary career. The council of judges shall consider the election of either living or deceased persons.

For full details on documentation and other submission requirements, contact David Gideon at 561-237-6121, email him at david@mahf.com, or visit www.mahf.com.

 

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.